|
Al-Obeidi F, A., Wu, J. J. and Lam, K. S. (1998)Protein tyrosine kinases: structure, substrate specificity, and drug discovery. Biopolymers 47, 197-223. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M. and Fukami, Y. (1987) Genistein, a specific inhibitor of tyrosine kinase. J. Biol. Chem. 262, 5592-5595. Barnard, J. A., Graves, D. R., Pittelkow, M. R., DuBois, R., Cook, P. and Ram-sey, G. W. (1994) Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J. Biol. Chem. 269, 22817-22822. Benaud, C., Dickson, R. B. and Thompson, E. W. (1998) Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Res. Treatmemt 50, 97-116. Bishop, J. M. (1987) The molecular genetics of cancer Science 235, 305-311. Boege, F., Stranb, T., Kehr, A., Boesenberg, C. and Christiansen, K. (1996) Se-lected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J. Biol. Chem. 271, 2262-2270. Bradford, M. (1976) A rapid and sensitive method for the quantitation of micro-gram quantities of protein utilizing the protein-dye binding. Anal. Biochem. 72, 248. Chen, K., Kuo, S. C., Hsieh, M. C., Mauger, A., Lin, C. M., Hamel, E. and Lee, K. H. (1997) Antitumor agents. 178. Synthesis and biological evaluation of sub-stituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tu-bulin polymerization. J Med. Chem. 40, 3049-56. Cohen, S., Carpenter, G and King L. (1980) Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J. Biol. chem. 255, 4834-4842. Dean, N. M., Kanenitsu, M. and Boynton, A. L. (1989) Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells. Biochem. Biophys. Res. Commun. 165, 795.-801 Ferriola, P. C., Cody, V. and Middeton, E. Jr. (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem. Pharmacol. 38, 1617-1624. Fotsis, T., Pepper, M. S., Aktas, E.,. Breit, S., Rasku, S., Adlercreutz, H., Wa-hala, K., Montesano, R. and Schweigerer, L. (1997) Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 57,:2916-21. Gill, G. N. (1990) Regulation of EGF receptor expression and function. Mol. Reprod. Dev. 27, 46-53. Gullick, W. J. (1991) Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br. Med. Bull. 47, 87-98. Guthrie, N. and Carroll, K. K. (1998) Inhibition of mammary cancer by citrus flavonoids Adv. Exp. Med. Biol. 439, 227-236. Hendler, F. J. and Ozanne, B. W. (1984) Human squamous cell lung cancers express increased epidermal growth factor receptors. J. Clin. Invest. 74, 647-651. Hertog, M. G., Hollman, P. C. H., Katan, M. B. and Kormhout, D. (1993) Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer 20, 21-29. Hsuan, J. J. and Tan, S. H. (1997) Growth factor-dependent phosphoinositide signalling. Int. J. Biochem. Cell Biol. 29, 415-435 Huang, Y. T., Kuo, M. L. Liu, J. Y. and Huang, S. Y. (1996) Inhibitions of pro-tein kinase C and proto-oncogene expressions in NIH 3T3 cells by apigenin. Eur. J. Cancer 32, 146-151. Hunter, T. and Cooper, J. A. (1985) Protein tyrosine kinase. Annu. Rev. Biochem. 54, 897-930. Kandaswami, C., Perkins, E., Drzewieck, G., Soloniuk, D. S., Middleton, E. Jr. (1992) Differential inhibition of proliferation of human squamous cell carci-noma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. Anti-Cancer Drugs 3, 525-530. Karp, J. E., Chiarodo. A., Brawley, D. and Kelloff, G. J. (1996) Prostate cancer prevention: investigational approaches and opportunities. Cancer Res. 56, 5547-5556. Kelloff, G. J., Fay, J. R., Steele. V. E., Lubet, R. A., Boone, C. W., Crowell, J. A., and Sigman, C. C. (1996) Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives. Cancer Epidemiol. Biomarkers Prev. 5, 657-666. Klijn, J. G. M., Bern, P. M. J. J., Schmitz, P. I. M. and Foekens, J. A. (1992) The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr. Rev. 13, 3-17. Kondapaka, S. B., Fridman, R. and Reddy, K. B. (1997) Epidermal growth fac-tor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in hu-man breast cancer cells. Int. J. Cancer 70, 722-726. Levitzki, A. and Gazit, A. (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267, 1782-1788. Liotta, L. A. (1992) Cancer cell invasion and metastasis. Medicine Feb. 142-148. Liotta, L. A., Steeg, P. S. and Stetler-Stevenson, W. (1991) Cancer metastasis and angiogensis: an imbalance of positive and negative regulation. Cell 64, 327-336. Liotta, L. A., Steeg, P. S. and Stetler-Stevenson, W. (1989) Metalloproteinases and malignant conversion: does correlation imply causality ? J. Natl. Cancer Inst. 81, 556-557. Mabry, T. J. and Ulubelen, A. (1980) Chemistry and utilization of phenylpropa-noids including flavonoids, coumarins, and lignans. J. Pharm. Chim. Paris. 28, 188-196. Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185. Manthey, J. A. and Grohmann, K.. (1998) Flavonoids of the orange subfamily Aurantioideae. Archives Toxicol. 20, 1-7. Merlino, G. T., Xu, Y. H., Clark, A. J., Semba, K., Toyoshima, K., Yamamoto, T. and Pastan, I. (1984) Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science 224, 417-419. Monteagudo, C., Merino. M. J., San-Juan., J., Liotta, L. A. and Stetler-Stevenson, W. G.(1990) Immunohistochemical distribution of type IV colla-genase in normal, benign, and malignant breast tissue. Am. J. Pathol. 136, 585-592. Moyer, J. D., Barbacci, E. G., Iwata, K. K., Arnold, L., Boman, B., Cun-ninggham, A., DiOrio, C., Doty. J., Morin, M. J., and Moyer, M. M. (1997) In-duction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epi-dermal growth factor receptor tyrosine kinase. Cancer Res. 57, 4838-4848. Murray, P. A., Barrett-Lee, P., Travers, M., Luqmani, Y., Powles, T. and Coom-bes, R. C. (1993)The prognostic significance of transforming growth factors in human breast cancer. Br. J. Cancer 67, 1408-1412. Nakajima, M., Welch, D. R., Belloni, P. N. and Nicolson, G. L. (1987) Degra-dation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 47, 4869-4876. Neal, D. E., Marsh, C. Bennett, M. K., Abel, P. D., Hall, R. R. Sainsbury, J. R. and Harris, A. L.(1985)Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 336-368. Nicolson, G. L. (1989) Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr. Opin. Cell Biol. 1, 1009-1019. Pamukcu, A. M., Yalciner, S., Hatecher, J. F. and Bryan, G. T. (1980) Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquili-num). Cancer Res. 40, 3468-3472. Parmar, V. S., Jain, R., Sharma, S. K., Vardham, A., Jha, A. Taneja, P., Singh, S., Vyncke, B. M., Bracke, M. E. and Mareel, M. M. (1994) Anti-invasive activity of 3,7-dimethoxyflavone in vitro. J. Pharmaceutical Sci. 83, 1217-21. Patel, T., Gores, G. J. and Kaufmann, S. H. (1996) The role of proteases during apoptosis. FASEB 10, 587-597 Prigent, S. A. and Lemoine, N. R. (1992) The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog. Growth Factor Res. 4, 1-24. Salomon, D. S. Normanno, N., Ciardiello, F., Brandt, R., Shoyab, M. and To-daro, G. J. (1995) The role of amphiregulin in breast cancer. Breast Cancer Epi-demiol. Biomarkers Preven. 33, 103-144. Salvesen, G. S. and Pixit V. M. (1997) Caspases: intracellular signaling by pro-teolysis. Cell 91, 443-446. Sharoni, Y., Teuerstein, I.and Levy, J. (1986) Phosphoinositide phosphorylation precedes growth in rat mammary tumors. Biochem. Biophys. Res. Commun. 134, 876-882. Ullrich, A. and Schlessinger, J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212. Ullrich, A., Coussens, L., Hayflick, J. S. Dull, T. J.,. Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A. and Schlessinger, J. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309, 418-425. Wang, H. K., Xia, Y., Yang, Y. X. ZY., Morris Natschke, S. L. and Lee, K. H. (1998) Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. Adv. Exp. Med. Biol.. 439, 191-225. Wu, X., Fan, Z., Masui, H., Rosen, N., and Mendelsohn, J. (1995) Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J. Clin. Invest. 95, 1897-1905. Yasui, W., Hata, J. and Yokozaki, H Nakatani, H., Ochiai, A., Ito, H. and Tahara, E. (1988) Interaction between epidermal growth factor and its receptor in pro-gression of human gastric carcinoma. Int. J. Cancer 41, 211-217. Yasui, W., Sumiyoshi, H. and Hata, J Kameda, T., Ochiai, A., Ito, H. and Tahara, E. (1988) Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res. 48,137-141. Yasukawa, K., Takido, M, Takeuchi, M., Sato, Y., Nitta, K. and Nakagawa, S. (1990) Inhibitory effects of flavonol glycosides on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Chem. Pharm Bull. 38, 774-776. Yu, D. H. and Hung, M. C. (1990) Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene 6, 1991-1996. Zubay, G., Biochemistry. 3rd ed., U.S.A. :Wm. C. Brown, 1993.
|